Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
US FDA unveils new pathway to approve personalized therapies - 2'Here we go again': Businesses grapple with fuel costs
- 3Revealing the Specialty of Food Matching: Improving Culinary Encounters
- 4NASA's Artemis astronauts enter final preparations for Moon mission
- 5SF Chinatown's historic Empress of China building being revived into cultural campus
- Czech Republic caps fuel prices amid Iran war energy crisis
- The pace of hiring just fell to the lowest since 2011, outside of the pandemic
- Iran fires one of largest barrages in weeks ahead of Passover
- Dave Coulier shares new cancer diagnosis 1 year after revealing previous diagnosis
- Fascinating Fishing Objections From Around The World
- Allow Innovative Progressions To have a Tremendous Effect
- The most effective method to Help a Friend or family member Determined to have Cellular breakdown in the lungs
- Step by step instructions to Contrast Lab Jewels and Regular Ones
- The Best Computer games Ever
